3-(2-苯基乙基)苯甲酸 | 161373-05-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 中文名称: 3-(2-苯基乙基)苯甲酸
• 英文名称: 3-phenethylbenzoic acid
• 英文别名: 3-(2-Phenylethyl)benzoic acid
• CAS: 161373-05-3
• 化学式: C₁₅H₁₄O₂
• 分子量: 226.275
• InChiKey: JAHAEINDORLHMF-UHFFFAOYSA-N

物化性质

• 沸点：
  373.2±21.0 °C(Predicted)
• 密度：
  1.157±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 储存条件：
  存储条件：2-8℃，密封保存，置于干燥处。

反应信息

• 作为反应物：
  描述：

  3-(2-苯基乙基)苯甲酸 在 PPA 作用下， 以80%的产率得到10,11-二氢二苯并[a,b]环庚烯-5-酮
  参考文献：
  名称：

  Stǎnescu, Michaela Dina; Dincǎ, Nicolae; Şişu, Eugen, Revue Roumaine de Chimie, 2006, vol. 51, # 7-8, p. 669 - 673

  摘要：

  DOI：
• 作为产物：
  描述：

  (E)-methyl 3-styrylbenzoate 在 5percent Pd/C sodium hydroxide 、 氢气 作用下， 以 甲醇 、 乙醇 、 乙酸乙酯 为溶剂， 20.0 ℃ 、250.0 kPa 条件下， 反应 15.67h， 生成 3-(2-苯基乙基)苯甲酸
  参考文献：
  名称：

  4-Aminoquinolines:  Novel Nociceptin Antagonists with Analgesic Activity

  摘要：

  Small-molecule nociceptin antagonists were synthesized to examine their therapeutic potential. After a 4-aminoquinoline derivative was found to bind with the human ORL1 receptor, a series of 4-aminoquinolines and related compounds were synthesized and their binding was evaluated. Elucidation of structure-activity relationships eventually led to the optimum compounds. One of the se compounds, N-(4-amino-2-methylquinolin-6-yl) -2-(4-ethylphenoxymethyl)benzamide hydrochloride (11) not only antagonized nociceptin-induced allodynia in mice but also showed analgesic effect in a hot plate test using mice and in a formalin test using rats. Its analgesic effect was not antagonized by the opioid antagonist naloxone. These results indicate that this nociceptin antagonist has the potential to become a novel type of analgesic that differs from mu -opioid agonists.

  DOI：

  10.1021/jm0002073

文献信息

• Inhibitors of histone deacetylase
  申请人：MethylGene, Inc.

  公开号：US06541661B1

  公开（公告）日：2003-04-01

  The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

  这项发明涉及抑制组蛋白去乙酰化酶。该发明提供了抑制组蛋白去乙酰化酶酶活性的化合物和方法。该发明还提供了治疗细胞增殖性疾病和病况的组合物和方法。
• Alpha-helical mimetics
  申请人：Lessene Guillaume Laurent

  公开号：US20080153802A1

  公开（公告）日：2008-06-26

  Benzoyl urea derivatives that are alpha helical peptides mimetics that mimic BH3-only proteins, compositions containing them, their conjugation to cell-targeting-moieties, and their use in the regulation of cell death are disclosed. The benzoyl urea derivatives are capable of binding to and neutralizing pro-survival Bcl-2 proteins. Use of benzoyl urea derivatives in the treatment and/or prophylaxis of diseases or conditions associated with deregulation of cell death are also described.

  公开了模拟α螺旋肽的苯甲酰脲衍生物，这些衍生物模拟BH3-仅蛋白，含有它们的组合物，它们与细胞靶向基团的结合，以及它们在调节细胞死亡中的用途。苯甲酰脲衍生物能够结合并中和促生存的Bcl-2蛋白。还描述了在治疗和/或预防与细胞死亡失调相关的疾病或症状中使用苯甲酰脲衍生物。
• Organometallic Complex, Light-Emitting Element, Display Device, Electronic Device, and Lighting Device
  申请人：Inoue Hideko

  公开号：US20110101854A1

  公开（公告）日：2011-05-05

  Provided are organometallic complexes that can exhibit phosphorescence. One of the novel organometallic complexes is represented by General Formula (G1). In General Formula (G1), R 1 represents any of an alkyl group having 1 to 6 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms which may have a substituent, and an aralkyl group having 7 to 10 carbon atoms which may have a substituent. In addition, R 2 represents any of an alkyl group having 1 to 6 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms which may have a substituent, and an aryl group having 6 to 12 carbon atoms which may have a substituent. Further, Ar represents an arylene group having 6 to 13 carbon atoms which may have a substituent. Further, M represents a Group 9 element or a Group 10 element.

  提供的是可以显示磷光的有机金属络合物。其中一个新型有机金属络合物由通用公式（G1）表示。在通用公式（G1）中，R1代表任何一种具有1至6个碳原子的烷基、具有5至8个碳原子可能带有取代基的环烷基以及具有7至10个碳原子可能带有取代基的芳烷基。此外，R2代表任何一种具有1至6个碳原子的烷基、具有5至8个碳原子可能带有取代基的环烷基以及具有6至12个碳原子可能带有取代基的芳基。另外，Ar代表一个具有6至13个碳原子可能带有取代基的亚芳基。此外，M代表第9族元素或第10族元素。
• [EN] ORGANOMETALLIC COMPLEX, LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE<br/>[FR] COMPLEXE ORGANOMÉTALLIQUE, ÉLÉMENT ÉMETTANT DE LA LUMIÈRE, DISPOSITIF D'AFFICHAGE, DISPOSITIF ÉLECTRONIQUE ET DISPOSITIF D'ÉCLAIRAGE
  申请人：SEMICONDUCTOR ENERGY LAB

  公开号：WO2011052516A1

  公开（公告）日：2011-05-05

  Provided are organometallic complexes that can exhibit phosphorescence. One of the novel organometallic complexes is represented by General Formula (G1). In General Formula (G1), R1 represents any of an alkyl group having 1 to 6 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms which may have a substituent, and an aralkyl group having 7 to 10 carbon atoms which may have a substituent. In addition, R2 represents any of an alkyl group having 1 to 6 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms which may have a substituent, and an aryl group having 6 to 12 carbon atoms which may have a substituent. Further, Ar represents an arylene group having 6 to 13 carbon atoms which may have a substituent. Further, M represents a Group 9 element or a Group 10 element.

  提供的是能够显示磷光的有机金属络合物。其中一个新颖的有机金属络合物由通用公式（G1）表示。在通用公式（G1）中，R1 代表的是任何一种具有1到6个碳原子的烷基、具有5到8个碳原子的可能带有取代基的环烷基以及具有7到10个碳原子的可能带有取代基的芳烷基。此外，R2 代表的是任何一种具有1到6个碳原子的烷基、具有5到8个碳原子的可能带有取代基的环烷基以及具有6到12个碳原子的可能带有取代基的芳基。进一步地，Ar 代表的是一个具有6到13个碳原子的可能带有取代基的亚芳基。此外，M 代表的是第9族元素或第10族元素。
• De-Novo Designed Library of Benzoylureas as Inhibitors of BCL-X_L: Synthesis, Structural and Biochemical Characterization
  作者：Ryan M. Brady、Amelia Vom、Michael J. Roy、Nathan Toovey、Brian J. Smith、Rebecca M. Moss、Effie Hatzis、David C. S. Huang、John P. Parisot、Hong Yang、Ian P. Street、Peter M. Colman、Peter E. Czabotar、Jonathan B. Baell、Guillaume Lessene

  DOI：10.1021/jm401948b

  日期：2014.2.27

  present our approach based on de novo structure-based drug design. Using known structural information from complexes engaging opposing members of the BCL-2 family of proteins, we designed peptidomimetic compounds using a benzoylurea scaffold to reproduce key interactions between these proteins. A library stemming from the initial de novo designed scaffold led to the discovery of ligands with low micromolar

  存活的BCL-2蛋白对于药物化学家而言是有吸引力的但具有挑战性的靶标。它们参与了许多（如果不是全部）肿瘤的发生和发展，使其成为开发新的抗癌疗法的主要靶标。我们介绍了基于从头结构的药物设计方法。利用来自参与BCL-2蛋白质家族相对成员的复合物的已知结构信息，我们使用苯甲酰脲支架设计了拟肽化合物，以再现这些蛋白质之间的关键相互作用。从初始从头词干的文库设计的支架导致与低微摩尔效力（配位体的发现ķ d = 4μM）和选择性BCL-X大号。这些化合物以不同于先前已知的BCL-2抑制剂的结合方式在规范的BH3结合槽中结合。我们的研究结果为针对具有挑战性的蛋白质-蛋白质相互作用类的新型拮抗剂的设计提供了见识。